C17orf37 anticorps

N° du produit ABIN7073498

Détail du produit anti-C17orf37 anticorps

Antigène: C17orf37 (Chromosome 17 Open Reading Frame 37 (C17orf37))

Reactivité: Souris, Rat

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp C17orf37 est non-conjugé

Application: Western Blotting (WB)

Réactivité croisée: Rat

Purification: Affinity purification

Immunogène: Recombinant protein corresponding to Mouse XTP4

Information d'application

Indications d'application: WB (M,R) 1:200-1:500

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: PBS, pH 7.4, 0.02 % sodium azide

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Détails sur C17orf37

Antigène: C17orf37 (Chromosome 17 Open Reading Frame 37 (C17orf37))

Autre désignation: XTP4 (C17orf37 Produits)

Synonymes: anticorps C17orf37, anticorps C35, anticorps ORB3, anticorps RDX12, anticorps XTP4, anticorps C19H17orf37, anticorps 1810046J19Rik, anticorps AI463380, anticorps Rdx12, anticorps migration and invasion enhancer 1, anticorps migration and invasion enhancer 1 S homeolog, anticorps mien1, anticorps mien1.S, anticorps MIEN1, anticorps Mien1

Sujet: During the past decade, the role of the ERBB2(neu/HER2) oncogene as an important predictor of patient outcome and response to various therapies in breast cancer has been clearly established. The C35 (C17orf37) is a novel tumor biomarker abundantly expressed in breast cancer. Identification of shared tumor-specific targets is useful in developing broadly applicable therapies. The C35 gene is located on chromosome 17q12, 505nucleotides from the 3' end of the ERBB2oncogene, the antigenic target for trastuzumab(Herceptin) therapy. The chromosomal arrangement of the genes encoding C35 andERBB2 is tail to tail.

Poids moléculaire: 12 kDa

ID gène: 103742

NCBI Accession: NP_079835

UniProt: Q9CQ86

Pathways: Cell RedoxHomeostasis